Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Not necessarily. News rather than nasdaq listing is going to drive share price. There are few possible news items apart from their various trial phases (oncology, covid, asthma): potential partnership (IBS), some collaboration like in Parkinson, some progress on vaccine collaboration with Merck, or even some news from various conferences they participate. I don't know 4D's plan, whether they will like to announce all good news after nasdaq listing or will have some items announced before Nasdaq listing to get US investors interest before listing and then blockbuster announcements after listing. Considering chart, Norwood selling coming to an end and even Nasdaq is not too long far, price should sustain at current level and more likely rise (and perhaps grow fast).
Tiziana published RNS of just participating and having pre recorded presentation at JP healthcare conference and its sp did very well. I think TILS and 4D management has very different approach. Tils publish frequent rns and interviews, whereas 4D does it only on important developments. Hopefully they will release some positive developments soon. SP is doing alright in past few days, but not able to grow faster due to Norwood selling (no rns due to him being less than 3% hopefully he finishes his shares soon and we get some positive rns to allow sp rise as it should).
I think we should be much ahead after a month. sp is held back by some background selling (perhaps Norwood or shorting) as actually there are more buys in last few days then sells shown on trades and still sp is pulled back by coule of %. But it is opportunity for anybody having cash as Norwood won't have much left and once he is done, sp normally shoots. e.g. rene was pulled down in Dec due to some big selling by few institutions but it has been doing well in past week. Here we have only one active seller with not much left and forthcoming rns for nasdaq voting and soon after nasdaq listing :) And after that 4D will publish all good data I believe.
I am pretty sure at the time of opening it was around 1.31, so 1.32+ price must be buy transaction. transaction history on https://www.londonstockexchange.com/stock/DDDD/4d-pharma-plc/trade-recap shows sell at 1.31 and buy at 1.33 at that exact time (6 milliseconds back :).
Forgot to mention shareholders of Tils as on particular past date and not current holders (that's why its share price tanked I believe) will get extra share.
Nasdaq listing itself won't uplift prices, but news (cancer trial part B results, or some partnership etc.) after Nasdaq listing will uplift it dramatically and it can be multiple times like Seres or many small biotech companies do on Nasdaq. Tils price (it has been on nasdaq for sometimes) went quite high and went down only after it split and declared shareholders will get separate company share (for its Breast Cancer treatment business). So Tils obviously went down after that split. I don't follow Tils much (don't like its directors going to interview every week and too many rns), but this much I know as its price spiked before split. So when its split share gets listed I believe its shareholders will get that as extra share for free.
waited this much through churning seeing all other shares growing 30-50-70% and then when our time is coming, selling at 10-20% gain will of course not be wise. Nasdaq listing and then one of data release, this will go boom.
Whenever buy orders come, there hits couple of small sells showing share price down. I believe it is strategy to frustrate retail investors to sell their shares. Most buys seem to be short closing or some big buy order filling as I don't believe they will let retail investors buy cheap shares in big qty. Today buys are much more than sells but still sp stays at same price. I think till some good rns drops and there is some retail investment coming share price will be held in this range. Currently shorters or big players collecting shares from retail investors who have no conviction and are impatient.
https://investorplace.com/2020/12/glsi-stock-why-greenwich-lifesciences-is-up-2000-today/
This share today shoot up over 2000% on positive result on breast cancer treatment. So in single day from $62M market cap to over $1.2 billions!! Now came down bit but still 1000% up. 4D once listed on nasdaq and publishing positive data on one of their many trials going on, can do wonders as well.
I also agree. 4D management has been good in timing interviews (unlike some other companies on AIM where directors go to interview every other week which clearly shows insecurity/fake worth). It's twitter handle is also responsible and doesn't tweet/retweet any useless things and only tweets relevant and worthy information. SITC event due to remote and using conference software audio quality wasn't great, but in covid not sure anything better could have been done. Not sure why they didn't publish more info on SITC posters if there was anything visible at event. RNS on SITC unfortunately happened just after pfizer virus that harmed share price as if it was few hours before SP would have jumped and then came back staying bit higher. But retail investors in AIM are not patient (me including but I am here as trust this company so will stay as long as it takes) so it is better that 4D is focusing on promoting it to institutional investors by hiring US PR agency.
Thanks for clarification, I know nothing on this but somebody said like that. What you say sounds more logical, thanks again.
Yeah, decent buys today.
Feels like it is controlled price playing in range of 90-93 p for few days. Somebody said US broker of 4D will buy shares from AIM and sell as ADR on US market to allow liquidity on NASDAQ, if that is the case, would company like price to be in this range to buy at low price and transfer to US and then release some data? I wish Nasdaq listing is sorted asap and we are out of these manipulation. This sp doesn't look like will rise slowly, it will spike boom when it is let loose or some news arrive and that's why is risky to be out of it.
Ppl mentioned in article, if you see linkedin profile of Gokul Swaminathan, 4D is only one of other companies apart from Merck in his companies of interest. Xue Liang also follows 4D. Daria Hazuda is there in the article and another article https://www.fiercebiotech.com/biotech/merck-taps-4d-pharma-for-bacterial-vaccine-r-d-project. This tweet put all links together. https://twitter.com/DiavMilas/status/1335227429837803520?s=20
MSD vax collab, 4D eligible for $347.5mn in milestones PER INDICATION x 3 indications = >$1bn: even if one of payment is activated it is almost 3 times of market cap. Merck will buy out 4D in future I believe. It is currently gift to get 4D shares at 92p.
Looks like I was right that we will have somebody named Donachi writing 1st message on this board on 3rd December. Do you know valuation of Seres?
On the contrary I feel enthused that Loac and 4D merger gets noticed. Look at their tweeter feed in September they claimed of launching investigations into some billion $ acquisitions. Acquisitions are done nobody noticed these fake firm claims. Ar least we are noticed in US, that is good news.
Seems bogus dubious firm just in business of having such wild news claims. Look at its tweeter feed: https://twitter.com/RigrodskyLong?s=09
300 followers and with such tweets only like it is fbi:)
I think big cause for current sp is Steven Oliveira (or his group). He sold twice at very crucial moments (6th Nov before SITC posters and last week on SEC nasdaq announcement) when share price gained good momentum and damped it down. He is also part owner of Loac, so must be link to nasdaq listing and suggested Loac to 4D. So I guess he is not active seller and just cashed bit (perhaps to arrange for his backstop arrangement of $5 million as part of merger). He/his group is owner in various pharma companies, one interesting I saw was Forte Bioscience ($FBRX) where is he is co-owner with Citadel :)
Bought 2,300 shares more but it showed as sell :) I was surprised to see lots of sells today but price sustaining above 93p. So I suspect, lots of sells being shown might be actually buys.